Uranium
Compare Stocks
2 / 10Stock Comparison
CCJ vs XOM
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
CCJ vs XOM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Uranium | Oil & Gas Integrated |
| Market Cap | $53.89B | $629.60B |
| Revenue (TTM) | $3.48B | $323.90B |
| Net Income (TTM) | $589M | $28.84B |
| Gross Margin | 29.4% | 21.7% |
| Operating Margin | 17.5% | 10.5% |
| Forward P/E | 77.2x | 15.0x |
| Total Debt | $1.02B | $43.54B |
| Cash & Equiv. | $1.11B | $10.68B |
CCJ vs XOM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cameco Corporation (CCJ) | 100 | 1138.5 | +1038.5% |
| Exxon Mobil Corpora… (XOM) | 100 | 326.7 | +226.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CCJ vs XOM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CCJ carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 10.9%, EPS growth 246.2%, 3Y rev CAGR 23.0%
- 9.8% 10Y total return vs XOM's 107.4%
- Lower volatility, beta 1.72, Low D/E 14.8%, current ratio 2.47x
XOM is the clearest fit if your priority is income & stability.
- Dividend streak 26 yrs, beta -0.15, yield 2.7%
- Lower P/E (15.0x vs 77.2x)
- 2.7% yield, 26-year raise streak, vs CCJ's 0.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.9% revenue growth vs XOM's -4.5% | |
| Value | Lower P/E (15.0x vs 77.2x) | |
| Quality / Margins | 16.9% margin vs XOM's 8.9% | |
| Stability / Safety | Lower D/E ratio (14.8% vs 16.3%) | |
| Dividends | 2.7% yield, 26-year raise streak, vs CCJ's 0.1% | |
| Momentum (1Y) | +157.4% vs XOM's +45.7% | |
| Efficiency (ROA) | 6.4% ROA vs CCJ's 6.0%, ROIC 8.6% vs 6.3% |
CCJ vs XOM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CCJ vs XOM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CCJ leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 93.1x CCJ's $3.5B. CCJ is the more profitable business, keeping 16.9% of every revenue dollar as net income compared to XOM's 8.9%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $3.5B | $323.9B |
| EBITDAEarnings before interest/tax | $912M | $59.9B |
| Net IncomeAfter-tax profit | $589M | $28.8B |
| Free Cash FlowCash after capex | $1.1B | $23.6B |
| Gross MarginGross profit ÷ Revenue | +29.4% | +21.7% |
| Operating MarginEBIT ÷ Revenue | +17.5% | +10.5% |
| Net MarginNet income ÷ Revenue | +16.9% | +8.9% |
| FCF MarginFCF ÷ Revenue | +30.3% | +7.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.4% | -1.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +45.2% | -11.0% |
Valuation Metrics
XOM leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 22.2x trailing earnings, XOM trades at a 82% valuation discount to CCJ's 124.6x P/E. On an enterprise value basis, XOM's 11.1x EV/EBITDA is more attractive than CCJ's 82.6x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $53.9B | $629.6B |
| Enterprise ValueMkt cap + debt − cash | $53.8B | $662.5B |
| Trailing P/EPrice ÷ TTM EPS | 124.56x | 22.17x |
| Forward P/EPrice ÷ next-FY EPS est. | 77.20x | 15.00x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 82.61x | 11.05x |
| Price / SalesMarket cap ÷ Revenue | 21.05x | 1.94x |
| Price / BookPrice ÷ Book value/share | 10.62x | 2.40x |
| Price / FCFMarket cap ÷ FCF | 71.65x | 26.66x |
Profitability & Efficiency
XOM leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
XOM delivers a 10.7% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $9 for CCJ. CCJ carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to XOM's 0.16x. On the Piotroski fundamental quality scale (0–9), CCJ scores 8/9 vs XOM's 3/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +8.8% | +10.7% |
| ROA (TTM)Return on assets | +6.0% | +6.4% |
| ROICReturn on invested capital | +6.3% | +8.6% |
| ROCEReturn on capital employed | +6.5% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 3 |
| Debt / EquityFinancial leverage | 0.15x | 0.16x |
| Net DebtTotal debt minus cash | -$92M | $32.9B |
| Cash & Equiv.Liquid assets | $1.1B | $10.7B |
| Total DebtShort + long-term debt | $1.0B | $43.5B |
| Interest CoverageEBIT ÷ Interest expense | 10.04x | 69.44x |
Total Returns (Dividends Reinvested)
CCJ leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CCJ five years ago would be worth $68,440 today (with dividends reinvested), compared to $27,178 for XOM. Over the past 12 months, CCJ leads with a +157.4% total return vs XOM's +45.7%. The 3-year compound annual growth rate (CAGR) favors CCJ at 65.3% vs XOM's 13.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +25.6% | +22.0% |
| 1-Year ReturnPast 12 months | +157.4% | +45.7% |
| 3-Year ReturnCumulative with dividends | +351.9% | +46.8% |
| 5-Year ReturnCumulative with dividends | +584.4% | +171.8% |
| 10-Year ReturnCumulative with dividends | +975.9% | +107.4% |
| CAGR (3Y)Annualised 3-year return | +65.3% | +13.7% |
Risk & Volatility
Evenly matched — CCJ and XOM each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than CCJ's 1.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CCJ currently trades 91.5% from its 52-week high vs XOM's 84.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.72x | -0.15x |
| 52-Week HighHighest price in past year | $135.24 | $176.41 |
| 52-Week LowLowest price in past year | $45.42 | $101.19 |
| % of 52W HighCurrent price vs 52-week peak | +91.5% | +84.2% |
| RSI (14)Momentum oscillator 0–100 | 46.7 | 53.2 |
| Avg Volume (50D)Average daily shares traded | 3.2M | 18.8M |
Analyst Outlook
XOM leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates CCJ as "Buy" and XOM as "Hold". Consensus price targets imply 8.0% upside for XOM (target: $160) vs 1.7% for CCJ (target: $126). For income investors, XOM offers the higher dividend yield at 2.69% vs CCJ's 0.14%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $125.91 | $160.43 |
| # AnalystsCovering analysts | 19 | 55 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | +2.7% |
| Dividend StreakConsecutive years of raises | 2 | 26 |
| Dividend / ShareAnnual DPS | $0.24 | $4.00 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.2% |
XOM leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). CCJ leads in 2 (Income & Cash Flow, Total Returns). 1 tied.
CCJ vs XOM: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CCJ or XOM a better buy right now?
For growth investors, Cameco Corporation (CCJ) is the stronger pick with 10.
9% revenue growth year-over-year, versus -4. 5% for Exxon Mobil Corporation (XOM). Exxon Mobil Corporation (XOM) offers the better valuation at 22. 2x trailing P/E (15. 0x forward), making it the more compelling value choice. Analysts rate Cameco Corporation (CCJ) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CCJ or XOM?
On trailing P/E, Exxon Mobil Corporation (XOM) is the cheapest at 22.
2x versus Cameco Corporation at 124. 6x. On forward P/E, Exxon Mobil Corporation is actually cheaper at 15. 0x.
03Which is the better long-term investment — CCJ or XOM?
Over the past 5 years, Cameco Corporation (CCJ) delivered a total return of +584.
4%, compared to +171. 8% for Exxon Mobil Corporation (XOM). Over 10 years, the gap is even starker: CCJ returned +975. 9% versus XOM's +107. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CCJ or XOM?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
15β versus Cameco Corporation's 1. 72β — meaning CCJ is approximately -1275% more volatile than XOM relative to the S&P 500. On balance sheet safety, Cameco Corporation (CCJ) carries a lower debt/equity ratio of 15% versus 16% for Exxon Mobil Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — CCJ or XOM?
By revenue growth (latest reported year), Cameco Corporation (CCJ) is pulling ahead at 10.
9% versus -4. 5% for Exxon Mobil Corporation (XOM). On earnings-per-share growth, the picture is similar: Cameco Corporation grew EPS 246. 2% year-over-year, compared to -14. 5% for Exxon Mobil Corporation. Over a 3-year CAGR, CCJ leads at 23. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CCJ or XOM?
Cameco Corporation (CCJ) is the more profitable company, earning 16.
9% net margin versus 8. 9% for Exxon Mobil Corporation — meaning it keeps 16. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CCJ leads at 16. 7% versus 10. 5% for XOM. At the gross margin level — before operating expenses — CCJ leads at 26. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CCJ or XOM more undervalued right now?
On forward earnings alone, Exxon Mobil Corporation (XOM) trades at 15.
0x forward P/E versus 77. 2x for Cameco Corporation — 62. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for XOM: 8. 0% to $160. 43.
08Which pays a better dividend — CCJ or XOM?
All stocks in this comparison pay dividends.
Exxon Mobil Corporation (XOM) offers the highest yield at 2. 7%, versus 0. 1% for Cameco Corporation (CCJ).
09Is CCJ or XOM better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
15), 2. 7% yield, +107. 4% 10Y return). Cameco Corporation (CCJ) carries a higher beta of 1. 72 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (XOM: +107. 4%, CCJ: +975. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CCJ and XOM?
Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
XOM pays a dividend while CCJ does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.